Albumin-based drug delivery: harnessing nature to cure disease.

Larsen, Maja Thim; Kuhlmann, Matthias; Hvam, Michael Lykke; Howard, Kenneth A

Larsen, Maja Thim; Kuhlmann, Matthias; Hvam, Michael Lykke; Howard, Kenneth A.

Afiliación

Larsen MT; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark.
Kuhlmann M; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark.
Hvam ML; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark.
Howard KA; Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark.

Mol Cell Ther ; 4: 3, 2016.

Article en En | MEDLINE | ID: mdl-26925240

Palabras clave

Albumin fusions; Albumin-binding; Drugs; Half-life extension; Human serum albumin (HSA); Intracellular delivery; Molecular medicine; Neonatal Fc receptor (FcRn); Targeted drug delivery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Cell Ther Año: 2016 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Cell Ther Año: 2016 Tipo del documento: Article País de afiliación: Dinamarca